105 related articles for article (PubMed ID: 7427204)
1. Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device.
Booth M; Beral V; Guillebaud J
Br Med J; 1980 Jul; 281(6233):114. PubMed ID: 7427204
[TBL] [Abstract][Full Text] [Related]
2. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
O'Brien FB; Stewart WC; Sturtevant FM
Contraception; 1983 Feb; 27(2):111-22. PubMed ID: 6851553
[TBL] [Abstract][Full Text] [Related]
3. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA
Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
[TBL] [Abstract][Full Text] [Related]
4. Five years private practice experience of nulliparous women using copper IUD's.
Smith RP; Goresky DM; Etchell DM
Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
[TBL] [Abstract][Full Text] [Related]
5. A review of the use of intrauterine devices in nulliparous women.
Graham S; Simcock BW
Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine contraceptive device and pelvic inflammatory disease.
Toivonen J
Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices and pelvic inflammatory disease: an international perspective.
Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
[TBL] [Abstract][Full Text] [Related]
8. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
Roy S; Azen C
Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
[TBL] [Abstract][Full Text] [Related]
9. Pelvic inflammatory disease and the intrauterine contraceptive device.
Wright EA; Aisien AO
Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine contraceptive device use and pelvic inflammatory disease.
Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
[TBL] [Abstract][Full Text] [Related]
11. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
Larsson B; Rodau S; Patek E
Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
[TBL] [Abstract][Full Text] [Related]
12. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
13. Copper IUDs, PID, and fertility in nulliparous women.
Struthers BJ
Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
[TBL] [Abstract][Full Text] [Related]
14. Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory disease and age.
Andolsek L; Teeter RA; Kozuh-Novak M; Wheeler R; Fortney JA; Rosenberg MJ
Int J Gynaecol Obstet; 1986 Jun; 24(3):217-23. PubMed ID: 2880761
[TBL] [Abstract][Full Text] [Related]
15. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
Senanayake P; Kramer DG
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
[TBL] [Abstract][Full Text] [Related]
16. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
Elhag KM; Bahar AM; Mubarak AA
J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
[TBL] [Abstract][Full Text] [Related]
18. Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women.
Roy S; Cooper D; Mishell DR
Am J Obstet Gynecol; 1974 Jun; 119(3):414-7. PubMed ID: 4827383
[TBL] [Abstract][Full Text] [Related]
19. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
Abdulla SH
J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
[TBL] [Abstract][Full Text] [Related]
20. Interception by post-coital IUD insertion.
Van Santen MR; Haspels AA
Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
